Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.56 |
| ▸ | CYP2E1 | P05181 | 3/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.56 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | USP19 | O94966 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | NAMPT | P43490 | 2/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29817426 | 1.00 | CYP3A4 (0.56) | CYP3A4CYP2C19CYP2C9CYP2D6CYP2E1 | |
| SCHEMBL24811030 | 0.88 | CYP2C9 (0.54) | CYP3A4CYP2C19CYP2C9CYP2D6CYP2E1 | |
| SCHEMBL29817737 | 0.88 | CYP2C9 (0.54) | CYP3A4CYP2C19CYP2C9CYP2D6CYP2E1 | |
| SCHEMBL29817700 | 0.86 | ASAH1 (0.57) | CYP3A4CYP2C19CYP2C9CYP2D6CYP2E1 | |
| SCHEMBL24810554 | 0.86 | ASAH1 (0.57) | CYP3A4CYP2C19CYP2C9CYP2D6CYP2E1 | |
| SCHEMBL24809374 | 0.83 | CYP2E1 (0.49) | CYP3A4CYP2C19CYP2C9CYP2D6CYP2E1 | |
| SCHEMBL29786324 | 0.83 | CYP2E1 (0.49) | CYP3A4CYP2C19CYP2C9CYP2D6CYP2E1 | |
| SCHEMBL24810552 | 0.81 | CYP2E1 (0.46) | CYP3A4CYP2C19CYP2C9CYP2D6CYP2E1 | |
| SCHEMBL29817570 | 0.81 | CYP2E1 (0.46) | CYP3A4CYP2C19CYP2C9CYP2D6CYP2E1 | |
| SCHEMBL24809787 | 0.81 | CYP2A6 (0.46) | CYP3A4CYP2C19CYP2C9CYP2D6CYP2E1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220411388-A1 | SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | BIAL R&D INVEST S A (PT) | 2022-12-29 | — | — | US | disclosed |
| CN-114787135-A | Substituted imidazole carboxamides and their use in the treatment of medical disorders | 比亚尔R&D投资股份公司 | 2022-07-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411388-A1 | SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | GBA1, GAA, CLN6 | CYP3A4 1987/4885CYP2C19 741/4885CYP2C9 1421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.